CLO24-092: Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Non–Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
Authors:
John Kelvin Lalusis
John Kelvin LalusisSt. Luke’s Medical Center, Quezon City, Philippines